<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Blood Work – TDK Research & Consulting</title>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<style>
body{margin:0;font-family:Segoe UI,Arial;color:#0a4ea1;background:#fff}
.header{background:linear-gradient(to right,#062f6a,#0a4ea1,#083b82);color:#fff;padding:40px;text-align:center}
.content{max-width:1000px;margin:60px auto;padding:0 30px;line-height:1.7}

/* info cards */
.cards{
  display:grid;
  grid-template-columns:repeat(auto-fit,minmax(250px,1fr));
  gap:25px;
  margin-top:50px;
}

.card{
  border:1px solid #d6e3f3;
  border-radius:10px;
  padding:25px;
  background:#f8fbff;
  box-shadow:0 6px 18px rgba(0,0,0,0.05);
}

.card h3{
  margin-top:0;
  color:#062f6a;
}
</style>
</head>
<body>

<div class="header">
  <h1>Blood Work</h1>
  <p>Biomedical Research Division</p>
</div>

<div class="content">
  <p>
    The Blood Work program at TDK Research & Consulting focuses on translational,
    blood-based diagnostics and functional assays for complex hemostatic and
    thrombotic disorders. This work integrates platelet biology, coagulation
    biochemistry, and protein–protein interaction analysis with computational
    modeling and experimental validation.
  </p>
  <p>
    Building on extensive experience in rare bleeding disorders—particularly
    platelet-type von Willebrand disease (PT-VWD)—this platform develops assays
    that move beyond static biomarkers toward <strong>functional,
    mechanism-driven diagnostics</strong>.
  </p>
  <p>
    The long-term goal is to enable rapid, mechanism-informed blood diagnostics
    that guide patient stratification and therapeutic decision-making.
  </p>

  <!-- INFO CARDS -->
  <div class="cards">
    <div class="card">
      <h3>Platelet-type VWD</h3>
      <p>
        Rare gain-of-function mutations in GPIbα cause pathological binding to
        von Willebrand factor, resulting in unstable platelet plugs and
        paradoxical bleeding. This program investigates mechanism, diagnostics,
        and peptide-based therapeutic strategies.
      </p>
    </div>

    <div class="card">
      <h3>Pre-eclampsia</h3>
      <p>
        Abnormal placental signaling and endothelial dysfunction drive
        hypercoagulability and vascular injury. Blood-based biomarker and
        functional assays are being explored to enable earlier risk prediction.
      </p>
    </div>

    <div class="card">
      <h3>Additional Bleeding Disorders</h3>
      <p>
        This platform extends to unexplained bleeding phenotypes, platelet
        function disorders, and rare coagulopathies where standard diagnostics
        fail to capture functional defects.
      </p>
    </div>
  </div>

</div>
</body>
</html>
